Literature DB >> 22770870

Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects?

Paolo Dell' Antone1.   

Abstract

Cancer cells have a greater need for energy and a ready supply of the building blocks necessary for the synthesis of macromolecules (nucleotides, protein, lipids) in order to duplicate genome and biomass. The hypothesis can be postulated that those precursors for synthetic processes, which can only be furnished by glycolysis, cannot be sufficiently recruited from external sources (the blood stream) and that glycolysis is necessarily markedly activated. It can also be hypothesized that the Krebs cycle, which also furnishes precursors for macromolecule synthesis to meet the requirements of proliferating cells, is depleted of intermediates. In view of its cyclic nature requiring not only pyruvate but also oxalacetate as the "last" metabolite of the reaction sequence for its sustenance, the Krebs cycle may be partially inactivated. While anaplerotic reactions and other sources (amino acids and fatty acids) could supply the cycle with intermediates, those pathways constitute futile cycles for amino and fatty acids as they would be partially degraded in the cycle and the intermediates thus obtained would be exported into the cytoplasm for synthetic processes with no advantage for the cell. It is also hypothesized that glutamine, an important fuel for cancer cells and playing a critical role in anaplerosis, may not contribute to reinforce the cycle; malate and α-ketoglutarate, two products of glutamine metabolism, might be exported from the mitochondria as precursors of biosynthetic pathways. It is possible then that malate, used for NADPH production required in the biosynthetic pathways, and glycerol-phosphate, too used for biosynthetic purposes (lipid biosynthesis), are unable to sustain the mitochondrial redox shuttles reducing the respiratory capacity of the mitochondria. Low shuttle capacity implies that NADH generated by glycolysis needs to be continuously re-oxidized in the cytoplasm via lactate dehydrogenase to maintain glycolysis fully activated, causing the abnormal lactate production observed in cancer. The paper goes onto discuss the essential role of glucose in cancer cell proliferation also in inducing the Crabtree effect. It is finally hypothesized that respiration inhibition after cancer cells have been supplied with glucose is due to reactivation in a suited medium of biosynthetic pathways with the consequences described above.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22770870     DOI: 10.1016/j.mehy.2012.06.002

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  24 in total

Review 1.  Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.

Authors:  Archana Bhaw-Luximon; Dhanjay Jhurry
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-09       Impact factor: 4.553

2.  BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume.

Authors:  Nicholas Theodosakis; Matthew A Held; Alexander Marzuka-Alcala; Katrina M Meeth; Goran Micevic; Georgina V Long; Richard A Scolyer; David F Stern; Marcus W Bosenberg
Journal:  Mol Cancer Ther       Date:  2015-05-06       Impact factor: 6.261

3.  Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.

Authors:  Marcin Mardas; Marta Stelmach-Mardas; Radosław Madry
Journal:  Support Care Cancer       Date:  2016-10-22       Impact factor: 3.603

4.  An indispensable role of CPT-1a to survive cancer cells during energy stress through rewiring cancer metabolism.

Authors:  Jingtao Luo; Yun Hong; Xiaoan Tao; Xi Wei; Lun Zhang; Qiang Li
Journal:  Tumour Biol       Date:  2016-10-13

Review 5.  O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.

Authors:  John A Hanover; Weiping Chen; Michelle R Bond
Journal:  J Bioenerg Biomembr       Date:  2018-03-29       Impact factor: 2.945

6.  Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.

Authors:  Anna Wilk; Dorota Wyczechowska; Adriana Zapata; Matthew Dean; Jennifer Mullinax; Luis Marrero; Christopher Parsons; Francesca Peruzzi; Frank Culicchia; Augusto Ochoa; Maja Grabacka; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

7.  p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis.

Authors:  Nicholas Theodosakis; Goran Micevic; Casey G Langdon; Alessandra Ventura; Robert Means; David F Stern; Marcus W Bosenberg
Journal:  J Invest Dermatol       Date:  2017-06-07       Impact factor: 8.551

8.  hsa-miR-4485 regulates mitochondrial functions and inhibits the tumorigenicity of breast cancer cells.

Authors:  Lakshmi Sripada; Kritarth Singh; Anastasiya V Lipatova; Aru Singh; Paresh Prajapati; Dhanendra Tomar; Khyati Bhatelia; Milton Roy; Rochika Singh; Madan M Godbole; Peter M Chumakov; Rajesh Singh
Journal:  J Mol Med (Berl)       Date:  2017-02-20       Impact factor: 4.599

9.  Vitamins, metabolomics, and prostate cancer.

Authors:  Alison M Mondul; Stephanie J Weinstein; Demetrius Albanes
Journal:  World J Urol       Date:  2016-06-23       Impact factor: 4.226

10.  Lack of Detectable Direct Effects of Silver and Silver Nanoparticles on Mitochondria in Mouse Hepatocytes.

Authors:  Lu Wang; Danielle F Mello; Robert M Zucker; Nelson A Rivera; Nicholas M K Rogers; Nicholas K Geitner; William K Boyes; Mark R Wiesner; Heileen Hsu-Kim; Joel N Meyer
Journal:  Environ Sci Technol       Date:  2021-08-04       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.